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Abstract
Ectopically expressed human KV10.1 channels are relevant players in tumor biology. However, their function as ion channels
at the plasma membrane does not totally explain their crucial role in tumors. Both in native and heterologous systems, it has
been observed that a majority of KV10.1 channels remain at intracellular locations. In this study we investigated the
localization and possible roles of perinuclear KV10.1. We show that KV10.1 is expressed at the inner nuclear membrane in
both human and rat models; it co-purifies with established inner nuclear membrane markers, shows resistance to detergent
extraction and restricted mobility, all of them typical features of proteins at the inner nuclear membrane. KV10.1 channels at
the inner nuclear membrane are not all transported directly from the ER but rather have been exposed to the extracellular
milieu. Patch clamp experiments on nuclei devoid of external nuclear membrane reveal the existence of channel activity
compatible with KV10.1. We hypothesize that KV10.1 channels at the nuclear envelope might participate in the homeostasis
of nuclear K
+, or indirectly interact with heterochromatin, both factors known to affect gene expression.
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Introduction
KV10.1 (Ether-a `-go-go-1, KCNH1) is a voltage-gated potassium
channel expressed almost exclusively in the mammalian central
nervous system, where its physiological roles have not been clearly
identified. Intriguingly, over 70% human tumors of various origins
show KV10.1 expression [1,2,3,4,5,6,7] the intensity of which
correlates negatively with survival in some sarcomas [8] and
leukemias [9]. It has also been shown that KV10.1 not only plays a
role in oncogenic transformation and malignancy, but also that the
proliferation of cancer cells is dependent on its expression [10]. It
nevertheless remains unclear if K
+ permeation is required for the
carcinogenic properties of KV10.1. On one hand, a KV10.1 open
channel blocker [11] and a monoclonal antibody against KV10.1
[12] both of which inhibit ion flow, are able to reduce xenograft
tumor growth in immunodeficient mice. On the other hand, the
Drosophila ortholog eag is also known to induce an increase in cell
proliferation independently of ion influx [13], and a non-
conducting KV10.1 point mutant still promotes tumor progression,
although to a reduced extent [11]. Also, not every K
+ channel
shows a similar behavior. For example, KV10.5, the closest relative
to KV10.1, possesses very similar electrophysiological properties,
but is not carcinogenic [11].
Interactions of the channels with signaling cascades within the
cell could explain these effects without ion permeation. This is in
line with the observation that the vast majority of KV10.1 protein
remains in intracellular pools, including the perinuclear region, in
either heterologous systems [14], neurons [15] or tumor cells [16].
It has also been reported that KV10.1 plays a role in oxygen
homeostasis and angiogenesis independently of K
+ flow [11],
which would provide an advantage to tumor cells but does not
explain the observations reported in vitro.
During the eukaryotic interphase, nucleoplasm and cytoplasm
constitute two distinct compartments separated by the nuclear
envelope, and trafficking between compartments is allowed by the
nuclear pore complex (NPC). Small (,40 KDa) soluble proteins
can cross the NPC freely, while larger molecules are active and
selectively transported [17]. The nuclear envelope is a membra-
nous structure composed of two layers, the inner and the outer
nuclear membranes (INM and ONM, respectively), and the space
between is termed the perinuclear space. The ONM is an
extension of the ER but shows a distinct protein composition,
different from that of the rest of the reticulum [18]. Consequently,
the perinuclear space is continuous with the lumen of the ER. The
protein composition of the INM is radically different from that of
the ONM and the ER. Only a handful of transmembrane proteins
are known to reach the INM [19].
As a particular type of complex transmembrane protein, ion
channels have also been found in the nuclear envelope [20]. Most
reports refer to channels in the ONM, while, to our knowledge,
only few channels have been reported to date at INM. Marchenko
et al. [21] describe the inositol 1,4,5-trisphosphate (InsP3) receptor,
Longin et al. [22] a zinc and a calcium channel, Rousseau et al.
[23] report two chloride conductances and a non-selective cation
channel, and Fedorenko et al., describe a large conductance non-
selective cation channel in both the ONM and the INM [24];
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19257among all of them, only the InsP3 receptor has an identified
molecular identity.
The permeability of the NPC to small ions is still under debate.
If it would not be permeable to ions, the ionic composition should
be different between the nucleoplasm and cytoplasm, and there
could be an electrical potential across the nuclear envelope.
However, there are few reports on the ion composition of the
nucleoplasm [25,26] and, in most cases, the intranuclear potential
is only slightly negative compared to the cytoplasm [20] but is still
dependent on the cytoplasmic K
+ concentration [27]. On the
other hand, there are compelling electrophysiological studies
where it has been proposed that the NPC can close in a voltage-
dependent manner in the absence of cargo, and that ion flow is
prevented when the pore is occluded by cargo [28]. This makes it
possible for channels at the INM to dampen or amplify
cytoplasmic Ca
2+ transients into the nucleoplasm [29]. From an
experimental point of view, the existence of a diffusion barrier also
allows measurement of currents from other smaller channels on
either the outer or the INM. It should also be noted that the
activity of channels at the INM could participate in the regulation
of ion exchange between the nucleoplasm and the perinuclear
space, which is continuous with the ER lumen but not the cytosol.
In any case, it cannot be ruled out that such ion channels may
have functions independent of ion permeation.
In the present report, we provide evidence showing that KV10.1
is located to the INM and that currents compatible with KV10.1
can be detected by patch clamp at the INM. We also show that
INM KV10.1 might interact with heterochromatin. We discuss
these findings in light of the role of KV10.1 in cancer, as the INM
has been shown to affect gene expression, genome stability and cell
senescence, all of which are relevant to cancer [30].
Results
KV10.1 localizes to the perinuclear region of native and
transfected cells
There is compelling electrophysiological, microscopical and
biochemical evidence that KV10.1 is a plasma membrane channel.
However, immunostainings of neurons, transfected cells, tumors
and tumor cells, as well as in vivo observation of KV10.1 labeled
with fluorescent proteins (DsRed2, EGFP and mVenus) in
different cell types (NIH3T3, CHO, HEK293), revealed perinu-
clear localization of the protein in 53% of ts20 cells (n=156) and
11% of CHO cells (n=203) in the form of a thin line compatible
with the nuclear envelope (Fig. 1A, B). Depending on the cell line
used, there were roughly 20–40% of cells exhibiting a perinuclear
staining pattern possibly indicating an unrevealed role of KV10.1
in a particular cellular function.
To confirm this observation, we performed co-localization
experiments with lamin A/C as a nuclear envelope marker using
double staining with antibodies in HeLa cells expressing
endogenous KV10.1. A significant level of co-localization was
observed (Fig. 1D). This localization is not dependent on Golgi
integrity, since it is not abolished by brefeldin A (50 mM)
treatment, nor does it entirely co-localize with the ER, as
revealed by co-transfection of DsRed-tagged KV10.1 and a YFP-
ER marker (data not shown). The C-terminus of KV10.1 exhibits
a bipartite nuclear localization signal. We deleted this sequence to
test its influence in the perinuclear localization of KV10.1. For
this purpose, we used an EGFP-tagged version of KV10.1. The
deleted mutant still preserves electrophysiological activity when
expressed in Xenopus oocytes (data not shown). However, we did
not observe abolition of the perinuclear signal (Fig. 1C), and
therefore concluded that the identified nuclear localization
signal of KV10.1 is not required for its targeting to the nuclear
envelope.
In heterologous systems and tumor cells, although not in the
brain, it could be argued that the expression of the channel in the
nuclear envelope is an artifact of massive overexpression. If this
were the case, one would expect a positive correlation between
overall expression levels and INM expression. However, detailed
image analysis revealed that the perinuclear fluorescence intensity
of KV10.1 did not correlate with cytoplasmic intensity: 91% of
ts20 cells showed higher perinuclear than cytoplasmic fluores-
cence intensity in the immediately neighboring region (n=90). In
19% of cells, the perinuclear intensity was at least twice as high
than the cytoplasmic one (see examples in Figure 1). Inhibition of
de novo protein synthesis by cycloheximide (10 mg/mL for 1–
12 hours) did not abolish the perinuclear localization, also
arguing against an overexpression artifact (data not shown). This
suggests that, even in overexpression systems, the localization of
KV10.1 to the nuclear envelope involves a specific regulatory
mechanism.
The proximity of ONM and INM (at the scale of 40 nm
[31]) is far beyond the resolution of standard confocal
microscopy. We therefore carried out post-embedding immu-
noelectron microscopy on samples showing endogenous KV10.1
expression using mAb62 antibodies. Approximately 90% of gold
particles labeling KV10.1 channels were detected on the INM of
both the human cancer cell line MCF-7 (Fig. 2A–C) and rat
cerebellum (Fig. 2D–E) and hippocampus (Fig. 2F–H). The rest
of gold particles were localized either in the ONM or in the
adjacent cytoplasm.
The perinuclear localization of KV10.1 is compatible with
the INM
The ONM is continuous with the ER, where integral
membrane proteins are synthesized. These proteins could, in
principle, diffuse to the ONM and result in a perinuclear
distribution pattern. To distinguish between external and INM
localizations, digitonin-permeabilization experiments are often
employed. Digitonin preferentially permeabilizes cholesterol-rich
membranes (e.g. plasma membrane) and consequently the
cholesterol-poor ER and nuclear envelope membranes remain
largely intact [32]. In the selectively permeabilized cells, antibodies
can only access the cytoplasmic side of ER/ONM proteins but
cannot reach the INM proteins, which are shielded by the nuclear
envelope. Because the ER lumen is topologically equivalent to the
extracellular space, the extracellular domains of KV10.1 should
face the ER lumen or the perinuclear space, while the C-terminus
is expected to face the cytoplasm [33]. Antibodies could therefore
not access the INM KV10.1, regardless of its orientation, as long as
the ONM is intact.
CHO cells transiently transfected with KV10.1-mVenus were
permeabilized either thoroughly with Triton X-100 or selectively
with digitonin, and then probed with antibodies recognizing either
an extracellular loop (mAb66) or the intracellular C-terminus
(mAb33) (Fig. 3). In the Triton X-100 permeabilized cells, signals
from the KV10.1-mVenus channel perfectly overlapped with the
immunofluorescent staining (Fig. 3 Bc,d and Cc,d). In cells
permeabilized with digitonin, mAb66 was unable to label the
intracellular KV10.1 (Fig. 3 Ba,b), suggesting that the integrity of
ER/nuclear envelope was preserved, and that the extracellular
regions of ER KV10.1 face the lumen. In contrast, mAb33 (Fig. 3
Ca,b) mostly stained the intracellular KV10.1, but failed to label
KV10.1 located at the perinuclear rim, indicating that perinuclear
KV10.1 localized to a subcellular compartment distinct from the
ER/ONM but compatible with the INM. Consistent staining
Nuclear KV10.1 Channels
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KV10.1 (not shown) and are therefore unlikely to be an effect of
the mVenus fusion.
During our microscopy experiments, we noticed that perinu-
clear KV10.1 was unevenly distributed, rather than being a
smooth line surrounding the whole nucleus. Similar discrete
nuclear envelope microdomains, devoid of NPC and therefore
termed ‘NPC-free islands’, have already been reported for nurim
[34], emerin [35] and the lamin B receptor (LBR) [36], which has
been shown to recruit heterochromatin. To test if the patched
distribution pattern of KV10.1 corresponds to NPC-free islands,
we performed double staining of KV10.1 and NPC constituents.
KV10.1 frequently resided at the region of low or no NPC
intensity, as indicated by a Manders Coefficient close to 0
(0.2760.17, n=15), although NPC is nearly ubiquitous in the
nuclear envelope. Perinuclear KV10.1 was often found to be close
to intense DAPI staining, which typically identifies heterochro-
matin (Fig. 4), also in live cells expressing KV10.1-mVenus and
stained with Hoechst 33342 (not shown).
KV10.1 localization to NPC-free islands and proximity to
heterochromatin may involve either a direct or an indirect
interaction with heterochromatin. INM proteins in direct contact
with histones can be detected in the ‘nuclear envelope-peripheral
heterochromatin fraction’ [37]. However, this was not the case for
KV10.1 in the HEK-KV10.1 cell line (data not shown) and we
therefore tested for indirect interactions. An indication of
heterochromatin formation in the case of certain INM proteins
is the loss of lamin A/C signals in immunostaining due to epitope
masking [38], although it can also be due to phosphorylation of
lamin itself [39,40]. As mentioned before, KV10.1 is localized to
the same areas as lamin A/C. A closer examination revealed that,
within those regions, KV10.1 was consistently localized to regions
with low lamin A/C fluorescence intensity. In 11/21 cells, KV10.1
signal covered 4765% of the perinuclear region, and there was a
Figure 1. Examples of perinuclear localization of KV10.1. A. NIH3T3 cells transfected with KV10.1-DsRed (wide field epifluorescence image of
living cell, 40x/0.75 Zeiss Achroplan water immersion objective). B. CHO cell transfected with KV10.1-DsRed2 (wide field epifluorescence image of
living cell, 63x/0.9 Zeiss Achroplan water immersion objective). Scale bars: 5 mm. C. Confocal image showing perinuclear localization of EGFP-
KV10.1DNLS (devoid of nuclear localization signal) in a living CHO cell (Zeiss LSM510Meta, Plan-Neofluar 40x/1.3 Oil DIC objective; scale bar: 10 mm).
D. Two examples of co-localization of KV10.1 with lamin A/C. HeLa cells fixed with methanol were stained with goat anti human lamin A/C (Di, Dv;
Alexa Fluor 546 donkey anti-goat secondary antibody) and rabbit polyclonal anti-KV10.1 (Dii, Dvi; donkey anti-rabbit FITC conjugated secondary
antibody) and antibodies. Diii, Dvii merged images. Div, Dviii, Co-localization display; grayscale intensity indicates colocalization (analyzed using FiJi).
Wide field epifluorescence image, 63x Zeiss Plan Apochromat 1.4 oil immersion objective. Scale bar: 10 mm. Gaussian blur (d=2 pixel) was applied to
all the images.
doi:10.1371/journal.pone.0019257.g001
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total intensity (compared to the average value in the same field of
view); in 5 cells, KV10.1 signal covered 7268% of the perinuclear
region, and there was a global reduction of the lamin A/C
fluorescence intensity-typical for ‘‘epitope masking’’; in the rest of
the cells, KV10.1 signal occupied 66610% of the perinuclear
region, but there was no obvious effect on lamin A/C signal
(Figure 5). This reduction of fluorescence could be rescued
partially by extraction with high concentration of salt or
incubation with DNase I, and a combination of both treatments
resulted in a nearly complete retrieval of lamin A/C fluorescence.
This can be interpreted as that the presence of KV10.1 correlates
with the formation of heterochromatin, either locally or globally,
which further masks the epitope of lamin A/C.
Perinuclear KV10.1 is resistant to Triton X-100 extraction
and shows restricted lateral mobility
Higher resistance to non-ionic detergent extraction also
characterizes INM proteins. To test this, CHO cells transiently
expressing KV10.1-mVenus were incubated with extraction buffer
containing 3% Triton X-100 before fixation and the fluorescence
obtained was examined by confocal microscopy. This extraction
removed the fluorescence signals from all the cytoplasm except in
the perinuclear region as compared to control cells (Fig. 6A,B).
The remaining punctate cytoplasmic structures have been
suggested to be aggregates resistant to extraction in similar
experiments on other INM proteins [41]. Triton X-100 extraction
was also applied to isolated nuclei from HEK-KV10.1 cells and
evaluated by western blotting. Efficiency of the detergent
extraction of the nuclear fraction was tracked by reduction of
the ER/ONM marker NADPH cytochrome c reductase. A
significant amount of KV10.1 remained in the non-extracted
(INM) fraction. A fraction of KV10.1 was also extracted, possibly
representing the ER/ONM (or other contaminating organelles)
pool of KV10.1 in this overexpression system (Fig. 6B, C).
INM proteins are typically subjected to various interactions at
the lamina layer and their lateral diffusion is therefore restricted as
compared to their ER counterparts. To compare the mobility of
KV10.1 in nuclear envelope and ER, we carried out 1-D FRAP
experiments in CHO cells expressing KV10.1-mVenus. Two strips
(2 mm wide) were bleached at both the nuclear envelope and ER,
and the recovery of fluorescence intensity was monitored for 5
minutes. The ER region regained the fluorescence almost
Figure 2. Electron micrographs show postembedding immunogold labeling for KV10.1 in MCF-7 cells (A–C), postnatal day 7
cerebellum (D–E) and adult pyramidal cells in CA1 (F–H). Gold particles are observed in the perinuclear inner membrane and/or adjacent to
the ONM. N=Nucleus, Scale bars: 0.1 mm.
doi:10.1371/journal.pone.0019257.g002
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recovered slowly and only partially (Fig. 7).
Quantitatively, nuclear envelope KV10.1 showed a smaller
mobile fraction than ER KV10.1 (54.364.3%, n=38 compared to
89.964.9%, n=33, p,0.001) and also a reduced diffusion
coefficient (4.460.8x 10
23 mm
2/s, n=38 compared to
10.362.1x 10
23 mm
2/s, n=33, p,0.001). These parameters are
consistent with those reported for other INM proteins
[42,43,44,45] and meet the criteria of an INM-targeted protein.
Again, the significant amount of immobile KV10.1 and the
restricted diffusion of the remaining mobile protein suggest to a
tight interaction of KV10.1 with its INM environment.
Subcellular fractionation of KV10.1 is compatible with
INM localization
We then set out to confirm the localization of KV10.1 to the
INM using biochemical tools. We purified nuclei from rat brain as
described in the Methods section. After ultracentrifugation
through sucrose cushions, nuclei were treated with citraconic
anhydride, which is described to specifically remove the ONM
[45,46]. The presence of KV10.1 and the well-established INM
proteins lamina-associated polypeptide 2 (LAP2) and LUMA was
investigated in the different fractions by western blot. KV10.1,
LAP2 and LUMA were all present predominantly in the nuclear
fraction in comparison to the total brain homogenate (Fig. 8A).
Removal of the ONM by citraconic anhydride (demonstrated by
a.10-fold reduction in cytocrome c reductase activity) resulted in
a concurrent enrichment of all three proteins, strongly suggesting
that KV10.1 is present in the INM in physiological conditions. In
Figure 3. Immunofluorescence microscopy of the intracellular
localization of KV10.1-mVenus. A. Schematic representation of the
topology of KV10.1 on different (intra)cellular membranes. Two relevant
domains of KV10.1 are show: the pore and intracellular C-terminus. Cells
in different permeabilized states are shown with red or yellow color
representing compartments that are accessible or inaccessible by
antibody-containing solution, respectively. In digitonin-permeabilized
cells, only the C terminal of ER/ONM KV10.1 is accessible while
antibodies can reach neither the pore of ER/ONM KV10.1 nor any
domain of the INM KV10.1. In Triton-permeabilized cells, all intracellular
KV10.1 is accessible by antibodies. Transiently transfected CHO cells
were permeabilized at 4uC by either digitonin (Ba,b; Ca,b) or Triton X-
100 (Bc,d; Cc,d), then fixed and labeled with anti-KV10.1 antibody
against either the pore (B) or the C-terminal (C). The corresponding
fluorescence from the mVenus tagged channel in both treatments is
shown in panels b and d. Gaussian blur (d=2 pixel) was applied to all
the images. Scale bar: 10 mm.
doi:10.1371/journal.pone.0019257.g003
Figure 4. Perinuclear KV10.1 is located to NPC-free islands.
A. Representative picture of a CHO cell transiently expressing KV10.1
and stained with anti-NPC antibodies (red) and anti-KV10.1 antibodies
(green). In the perinuclear region marked by the boundary of DNA
stained by DAPI (blue), KV10.1 is excluded from the region containing
NPC. Scale bar: 10 mm B. Enlargement of a perinuclear region from the
same cell. Scale bar: 2 mm C. The perinuclear region is shown
straightened to allow comparison between red and green fluorescence.
doi:10.1371/journal.pone.0019257.g004
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amount of KV10.1 was detected in the nuclear membrane fraction
and could be further enriched with LAP2 and LUMA by
citraconic anhydride treatment (Fig. 8B).
The relative abundance of KV10.1 in nuclear versus extranu-
clear fractions was much more evident in brain extract than in
transfected cells. This is compatible with ‘backed up’ localization
previously observed in the overexpression of other INM proteins
(LBR [42], MAN1 [47], nurim [41], LUMA [48] and emerin
[43]); this phenomenon occurs when an excess of INM proteins
saturates the INM retention sites, forcing accumulation in the ER
(also observed by immunofluorescence studies in the case of
KV10.1; data not shown).
Next, we addressed the questions whether KV10.1 at the INM
comes directly from the ER, or rather has been properly targeted
to the plasma membrane and only then transported to the nuclear
compartment. We performed enzymatic surface-biotinylation
experiments using a tagged KV10.1 channel that carries on an
extracellular loop the acceptor peptide (AP) that is recognized and
modified by the biotin protein ligase birA [49]. After 20 minutes or
24 hours of biotinylation reaction, the modified proteins were
pulled down and analyzed by western blot. Biotinylated KV10.1
was preferentially found in the nuclear fractions, and a significant
fraction was resistant to Triton X-100 extraction, indicating INM
localization (Fig. 9).
Altogether, our results suggest a tight retention of perinuclear
KV10.1, probably in association with detergent-resistant structures
such as lamina or chromatin.
Single channel activity compatible with KV10.1 is
detected in the INM
The above-described data do not answer the question whether
the channel located at the INM is functionally active. We therefore
set up to record single channels from both membranes of isolated
nuclei either directly approaching the envelope for ONM
measurement or after removal of the outer membrane with
citraconic anhydride for INM recordings.
Figure 5. Epitope masking of Lamin A/C in the presence of KV10.1. CHO cells transiently expressing KV10.1-mVenus (green) were extracted in
Triton X-100 (top panel) plus either DNase I (second panel from top), NaCl (third panel) on ice, or DNase I plus NaCl (bottom panel) at 37uC. Cells were
then stained with anti-lamin A/C antibodies (red). Note the reduced lamin A/C fluorescence in the upper panel and the rescue in the other three
panels. Scale bar, 20 mm.
doi:10.1371/journal.pone.0019257.g005
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to be suppressed to unmask smaller currents. In the absence of
Ca
2+, which was our initial condition because of the strong
inhibition of KV10.1 current in the presence of Ca
2+-calmodulin
[50], a large (1 nS) conductance was present in virtually every
membrane patch. This current was more evident upon de- or
hyper-polarization or mechanical stress. These currents could be
inhibited by known nuclear pore current blockers (mAb414, wheat
germ agglutinin [51], La
3+ and Zn
2+ [52] and are therefore
probably due to the NPC. Unfortunately, in our hands neither
mAb414 nor wheat germ agglutinin induced complete inhibition.
This made us rely on ionic blockers and to remove EGTA from
the recording solution, although EGTA was still used throughout
the purification process in an attempt to dissociate calmodulin
from KV10.1. Addition of W-7, a calmodulin antagonist, did not
significantly increase the chance of finding an active KV10.1
channel (data not shown), suggesting that calmodulin had indeed
been effectively removed during EGTA washing. For recording,
EGTA was thoroughly washed out and 10 mML a
3+ was added to
the solution. We chose this concentration because it had no
evident effect on plasma membrane KV10.1, which is also
inhibited by extracellular La
3+ with an apparent IC50 of
approximately 200 mM.
In asymmetrical potassium at 0 mV, we detected channel
activity with a conductance compatible with KV10.1. In
symmetrical potassium, large conductance activity was more
frequently observed in untreated, ONM preparations. We were
unable to record reliable single channel traces from them and they
will not be discussed here further. On the other hand, of 64
citraconic anhydride-treated nuclei, 27 records still showed NPC
current and were thereby excluded from further analysis, 17 nuclei
showed no activity, while the remaining 20 showed comparatively
small channel openings. These openings were compatible with
KV10.1 in terms of conductance (8.160.4 pS; Fig. 10A, B) and
voltage dependence, with highest open probability at 260 mV
and lowest at +60 mV in the pipette, which would represent a
membrane potential of opposite sign in an inside-out configura-
tion, that is, if the extracellular side of the channel faces the pipette
and the intracellular domains are located to the nucleoplasm. We
did not detect any comparable activity in 11 NPC-current-free
preparations from non-transfected cells. In asymmetrical K
+,
single channels with voltage dependence similar to the one
expected for KV10.1, most remarkably the severe dependence of
the activation time constant on the prepulse potential described for
this channel and commonly used to identify it (see e.g. ref [10])
and a chord conductance of 8.360.6 pS was detected (Figure 10
B, C). To characterize the pharmacology of the channel, we used
astemizole, a H1 histamine receptor inhibitor often used as blocker
of KV10.1, because it has not been reported to block conductances
other than those of the eag family including KV10.1 at a
concentration of 2–5 mM. In asymmetrical potassium, we
performed continuous recordings at 0 mV to avoid contamination
by channels other than those selective for K
+; under this condition,
the activity compatible with KV10.1 virtually disappeared in 7/7
patches after application of astemizole. In those cases that allowed
washout of the drug (3/7), the activity was recovered. Figure 11 A
depicts a similar experiment, but performed at +60 mV to increase
current amplitude. In symmetrical K
+, this treatment reduced the
open probability at +60 mV (membrane potential) by 94610%
(n=5), also indicating a blockade of the channel by astemizole.
Since the extracellular side of the channel appeared to be facing
the pipette, we used mAb56, a monoclonal antibody reported to
bind to the extracellular loops of KV10.1 and inhibit current [12].
To do this, we performed layered loading of the pipette by
backfilling the antibody-containing solution (45 mg/mL) over
antibody-free solution, to allow recording of channel activity prior
to the diffusion of the antibody to the pipette tip. The channel
activity decreased in all patches tested (n=6) within 10–20
minutes of the presence of mAb56, a time course compatible with
the described action of mAb56 on KV10.1 whole-cell current in
the plasma membrane (Fig. 11B). Under this experimental setup it
is not possible to fully discard a spontaneous rundown of the
Figure 6. Perinuclear KV10.1 is resistant to Triton X-100
extraction. CHO cells transfected with KV10.1-mVenus were incubated
without (A) or with (B) 3% Triton X-100 for 5 min, fixed and analyzed by
confocal microscopy. Triton X-100 largely extracted the cytoplasmic
signal, while the perinuclear signal was still detected. Scale bar: 10 mm.
C. Western blot analysis using anti-KV10.1 antibody on total cell extract,
crude nuclear extract and nuclei extracted with 0.5% Triton X-100 from
HEK293 cells stably expressing KV10.1. Enrichment in nuclear proteins
was followed by reduction of NADPH cytochrome c reductase activity.
doi:10.1371/journal.pone.0019257.g006
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PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e19257Figure 7. Quantitative FRAP analysis of lateral diffusion of KV10.1 in CHO cells transiently expressing KV10.1-mVenus. A. Example of
the photobleaching process in the perinuclear region and ER (boxes). The recovery is shown at 0, 10 and 300 seconds after bleaching. B, Lower panel
shows the average normalized fluorescent intensity during recovery from all cells (6s.e.m.). The first 10 data points were taken every 0.47 seconds,
the next 15 every 5 seconds and the last 15 every 20 seconds. The black solid lines are the result of fitting as described in Material and Methods. The
initial 40 seconds of recovery are shown normalized in the inset.
doi:10.1371/journal.pone.0019257.g007
Figure 8. KV10.1 proteins can be co-purified from the INM fraction with other INM proteins. The nuclear membrane fraction either from
rat brain homogenate (A, n=3) or HEK293 cells stably expressing KV10.1 (B, n=4) was sedimented by sucrose gradient ultracentrifugation and the
ONM was further removed by citraconic anhydride treatment. Proteins from whole cell extract, nuclear fraction (lane 2) and nuclei without the ONM
were immunoblotted using anti-KV10.1, anti-LUMA and anti-LAP2 antibodies. Quantification corresponds to the relative densitometry measurements
for each lane (mean6s.e.m.).
doi:10.1371/journal.pone.0019257.g008
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not observe rundown in the time range used in these experiments.
Due to the selectivity of mAb56, this result strongly supports the
molecular identity of the detected channel as KV10.1, as well as
the proposed orientation in the INM implied by the above
experiments, namely that the intracellular C-terminus faces the
nucleoplasm.
In addition to the activity attributed to KV10.1, it is noteworthy
that we also detected other conductances in the range of 20–
40 pS, which were unaffected by astemizole or mAb56.
Discussion
In contrast to traditional ideas, the nuclear envelope is
increasingly viewed as a permeability barrier to ions. Although
the NPC is generally believed to be responsible for the most of the
permeability of the nuclear envelope, there is no correlation
between NPC density and the resistivity of the nuclear envelope
[20]. In addition, the intranuclear voltage is dependent on
cytoplasmic potassium concentration and independent of mem-
brane potential [27]. Therefore, the NPC should be impermeable
to small ions in a physiological environment. The ONM, on the
other hand, seems to be quite leaky to small molecules, including
ions [53]. In this scenario, the structure responsible for the ionic
and electrical differences between the nucleoplasm and cytoplasm
should be the INM, and ion channels in this membrane would
therefore become relevant.
We report here, for the first time, the presence of a functional
voltage-gated (the InsP3 receptor is a ligand-gated Ca
2+ channel)
ion channel with a defined molecular identity in the INM. This
statement is based on both optical and electron microscope data as
well as biochemical evidence, both in native and heterologous
systems. It not only fulfills all the criteria of a transmembrane
protein localized to INM but it is also functional as an ion channel
conducting potassium. The evidence in favor of an INM
localization include i) inaccessibility to channel-specific antibodies
after digitonin permeabilization, ii) resistance to Triton X-100
extraction, iii) limited lateral diffusion, iv) co-segregation with
established INM markers and v) electron microscopy. We have
used citraconic anhydride to remove the ONM. Other reports
have used citric acid or Triton X-100 for the same purpose, but
both have the disadvantage that they can also extract INM
proteins and make electrophysiological recordings more difficult
[54,55]. Additionally, our electrophysiological experiments indi-
cate the protein orientation; the extracellular loops of the channel
face the pipette, which favors localization at the INM. The identity
of the channel as KV10.1 is supported not only by the fact that it is
not found in wild-type nuclei, but also by its voltage dependence-
particularly dependence on the prepulse potential-single channel
conductance and pharmacology, most importantly by the
Figure 9. Biotinylated KV10.1-AP is detected in the inner nuclear envelope after labeling of the plasma membrane channel. After
enzymatic biotinylation, cytoplasmic and nuclear extracts were pulled down (A) with streptavidin-magnetic beads. KV10.1-AP was detected in the
nuclear fraction and resistant to detergent extraction. As a control, (B) shows the total KV10.1-AP and LUMA signals from these extracts before pull-
down of biotinylated Kv10.1-AP. Densitometry for each lane is represented below the corresponding blot (mean6s.e.m, n=3).
doi:10.1371/journal.pone.0019257.g009
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selective blocker available.
We have devoted substantial efforts to make sure that this
distribution is not an overexpression artifact. First, INM
localization was also observed in native expression systems with
immunoelectron microscopy and subcellular fractionation. Sec-
ond, even in heterologous systems, the expression level in the
perinuclear region is not correlated with the level in the
cytoplasm, and protein synthesis inhibition does not alter the
perinuclear localization, arguing against aberrant relocation of
excess KV10.1. Third, a significant fraction of the AP tagged
protein at the INM has been exposed to the extracellular medium
Figure 10. Single channel recording from the INM of HEK-KV10.1 cells. A. Amplitude histogram of events recorded at +40 mV in symmetrical
potassium (pooled data from 5 independent recordings). B. Single channel amplitudes versus voltage in symmetrical (circles) or asymmetrical
potassium (squares). Error bars represent s.e.m. The solid line represents a linear fitting of the data that gives a slope conductance of 8.1 and 8.3 pS.
C. Traces recorded at +60 mV from a holding potential of 260 (blue) or 2100 mV (red). The latency time before the first opening is increased when
the holding potential is more negative, as clearly seen in the ensemble currents depicted in the inset. Scale bars: 2 pA, 500 ms.
doi:10.1371/journal.pone.0019257.g010
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arguing against saturation of the transport machinery. We cannot
exclude localization also in the ONM, especially in overexpres-
sion systems, but the specificity of this localization is more difficult
to establish.
Two major types of NLS have been described in the soluble
nucleoplasmic proteins SV40 large T antigen and nucleoplasmin.
Similar NLS have been predicted in the nucleoplasmic domains of
many INM proteins [56] and most of them reside in regions
essential for INM localization, as determined by deletion studies
(for emerin [43], MAN1 [44] and LEM2 [57], but not for LAP2-b
[58]). LBR shows a NLS in its nucleoplasmic domain, but can also
be targeted by its transmembrane domain [59]. On the other
hand, there is no predicted NLS for nurim, and LUMA has a
predicted NLS in its luminal domain [56], and both nurim and
LUMA depend on their transmembrane domains for targeting to
the INM [34,48]. SUN-2 bears two NLS at the nucleoplasmic
domain, but can be targeted by its luminal domain, which
possesses no known NLS [60]. In a similar way, while a conserved
bipartite NLS can be identified in the nucleoplasmic domain of
KV10.1, its deletion however does not significantly alter the INM
localization. Since the size of the nucleoplasmic domain of INM
proteins able to pass through the NPC during interphase is small
(,75 kDa) [56] and the fact that KV10.1 is only functional as a
tetramer, it is also possible that it is targeted to the INM during
reassembly of nuclear envelope in mitosis. However, the relatively
fast localization of biotinylated KV10.1 to the INM (Fig. 9) would
not be explained by such a mechanism.
The function of KV10.1 at this location remains only
speculative. It could partly underlie the oncogenic properties of
the channel. INM proteins play a role in gene expression
regulation [61] either by sequestering transcription factors,
repressors or other regulators or by direct interaction with
chromatin. Within the chromatin in the vicinity of the nuclear
envelope, genes encoded in areas close to the NPC are being
actively transcribed, while those located away from the NPC (in
heterochromatin) are often silent. We did not observe a direct
physical interaction of KV10.1 with heterochromatin, but the
presence of the channel correlated with the absence of NPC and
epitope masking of lamin A/C, which is compatible with
enrichment in heterochromatin. The physical structure of
heterochromatin influences not only transcription efficiency but
also splicing [62,63]. Additionally, K
+ ions increase the stability of
G-quadruplex structures [28,64] (inter or intramolecular non
Watson-Crick pairs in guanine-rich areas), which can act as
transcriptional repressor elements (for example of the myc
oncogene [65]). There is also abundant evidence of crosstalk
between INM proteins and proteins involved in signaling
pathways associated with cell cycle or carcinogenesis [66]. Results
from our laboratory unequivocally point to a crucial role of
KV10.1 channels at the plasma membrane, because a functional
antibody that blocks the current shows antitumor activity in vivo,
Figure 11. Pharmacological blockade of single channel currents from the INM of HEK-KV10.1. A. Block by astemizole. Traces obtained at
+60 mV in asymmetrical potassium before (control, black), during (astemizole, red) and after washing (wash, blue) 25 mM astemizole. Scale bars: 2 pA,
500 ms. B. Block by monoclonal antibody mAb56. Control trace, immediately after seal formation at 280 mV in the pipette (black), symmetrical
potassium. Red: Recording after 20 minutes incubation at the same voltage Scale bars: 0.5 pA, 500 ms.
doi:10.1371/journal.pone.0019257.g011
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present report indicates a cross talk between the pools of KV10.1 at
the plasma membrane and at the INM. This is conceptually
similar to the role of the C-terminus of a voltage-gated calcium
channel, which is cleaved and acts as a transcription factor [67].
There are also descriptions of transmembrane proteins that are
translocated from the plasma membrane to the INM [38]. Further
experiments to clarify this question are certainly warranted.
Materials and Methods
Cell culture and transfection
CHO-K1 (ACC 110), HEK293 (ACC 305), HeLa (ACC 57),
MCF-7 (ACC 115), and NIH3T3 (ACC 59) cells (all obtained
from DSMZ, Braunschweig, Germany) were grown, respectively,
in Ham’s F12 Nutrient mix, DMEM:F12, MEM, RPMI1640 and
DMEM medium, supplemented with 10% FCS at 37uCi na
humidified atmosphere with 5% CO2. Cells stably expressing
KV10.1 (HEK-KV10.1 and HEK-KV10.1-AP) were cultured in
the medium of the respective parental cell lines supplemented with
Zeocin (Calya, 3 mg/mL).
EGFP-KV10.1 was produced by cloning the open reading frame
of KV10.1 into pEGFPC2 (Clontech). To do this, an EcoRV site
was introduced at the start codon of KV10.1. KV10.1-DsRed and
KV10.1-DsRed2 were generated by introducing a SacI site at the
termination codon of KV10.1 and then cloning the full ORF into
pDsRedN1 and pDsRed2N1 (Clontech). The nuclear localization
signal was deleted by PCR. The pCDNA3.1 KV10.1-mVenus
construct was generated by replacing the stop codon of KV10.1 by
three alanine residues and inserting the coding sequence of
mVenus in frame (a mutant Venus-L221K- with less tendency to
multimerize). The full coding region was sequenced to ensure that
no additional mutation(s) had been introduced.
To mark surface expressed KV10.1, the acceptor peptide for
biotin ligase (AP) was inserted between the S3 and S4 loops of the
channel. This peptide is recognized and biotinylated by the
enzyme (BirA), which has only access to exposed parts. The
sequence: TGSSGSGSGGLNDIFEAQKIEWHEGGAGGAAG-
GTG was inserted after residue E317 of KV10.1 to produce
KV10.1-AP.
All tagged-KV10.1 exhibit the electrophysiological characteris-
tics of KV10.1 in heterologous expression systems (data not
shown). For transfection experiments, cells were plated on glass
coverslips and transfected at 70–90% confluence using Lipofecta-
mine 2000 (Invitrogen) following the manufacturer’s instructions.
Immunofluorescence staining and photobleaching experiments
were carried out 16–30 hours after transfection.
Immunofluorescence
Mouse monoclonal and rabbit polyclonal anti-KV10.1 antibod-
ies were generated in our laboratory and have been described
elsewhere [1]. mAb33 and polyclonal antibodies (2413 and 9391)
recognize the C-terminus of KV10.1, while mAb62, mAb66 and
mAb56 bind to the extracellular S5-S6 linker. For double staining
of the NPC and KV10.1, a commercial rabbit polyclonal antibody
was used (Alomone, Jerusalem, Israel).
Other antibodies used were goat anti human lamin A/C (Santa
Cruz Biotechnology, Santa Cruz, CA), mouse anti-NPC mono-
clonal antibody (mAb414, Abcam, Cambride, UK), rabbit
polyclonal anti-LAP2, which recognizes only the transmembrane
isoforms in LAP2 family, and anti-LUMA antibodies (kindly
provided by Henning Otto, Freie Universita ¨t Berlin, Germany).
For double staining of the NPC and KV10.1 [35], cells were
washed with TBS and fixed with 2% formalin solution (Sigma) for
15 minutes at room temperature. The reaction was quenched with
50 mM glycine for 5 minutes in HMK buffer (20 mM HEPES,
1 mM MgCl2, 100 mM KCl, pH 7.5), and the cells rinsed with
HMK, permeabilized with 0.5% Triton X-100 (Sigma) in HMK
for 5 minutes and incubated in 10% normal goat serum (NGS) in
HMK for 30 minutes. The cells were sequentially incubated with
rabbit anti-KV10.1 (1:1000, Alomone) in HMK buffer supple-
mented with 1% NGS, AlexaFluor 488 anti-rabbit antibody
(1:1000, Invitrogen), 1 mg/mL mouse anti-NPC and AlexaFluor
680-labeled anti-mouse antibody (1:1000 Invitrogen). Between
KV10.1 and NPC staining, we introduced a blocking step
with 10% NGS in HMK for 30 minutes. The coverslips were
mounted using DAPI-containing ProLong Gold Antifade reagent
(Invitrogen).
Lamin A/C staining and unmasking was performed as
described in (Isokane, Hieda et al. 2008) with modifications.
Briefly, CHO cells transiently expressing KV10.1-mVenus were
permeabilized for 10 minutes on ice in 20 mM Tris-HCl, 3 mM
MgCl2, 0.5 mM CuCl2, pH 7.5 with 0.4% Triton X-100. Then
the cells were extracted either on ice for 5 minutes with 0.5 M
NaCl or at 37uC for 20 minutes with DNase I (Qiagen, 80 U/mL)
or DNase I plus 0.5 M NaCl, washed, fixed and then blocked in
TBS plus 3% BSA for 1 hour, stained for 3 hours at 37uC against
lamin A/C at 1:100 dilution (Santa Cruz) and probed with anti-
goat AlexaFluor secondary antibodies (1:2000, 1 hour).
Detergent extraction and permeabilization experiments
For Triton X-100 extraction experiments, CHO cells transfect-
ed with KV10.1-mVenus were incubated on ice for 5 minutes with
or without 3% Triton X-100 in extraction buffer [41] (10 mM
HEPES, 80 mM KCl, 16 mM NaCl, 1.5 mM MgCl2,1 m M
DTT, 30% glycerol, and protease inhibitor mixture -Complete,
Roche Applied Science, pH 7.9). The cells were then fixed in 4%
p-formaldehyde at room temperature for 15 minutes and
incubated with 50 mM NH4Cl in PBS for 10 minutes and
mounted.
Digitonin permeabilization experiments were performed as
described in [59], with modifications. CHO cells transfected with
KV10.1-mVenus were fixed with 4% paraformaldehyde for 10
minutes at room temperature and incubated for 10 minutes in
50 mM NH4Cl in PBS. After that, the cells were incubated for 5
minutes at 4uCi n4 0mg/mL digitonin (diluted from a 20 mg/mL
DMSO stock), or 0.5% Triton X-100 in PBS. After a blocking step
with 10% BSA in PBS for 30 minutes, the cells were incubated
with the desired primary antibodies (either mAb66 or mAb33,
0.5 mg/mL) for 1 h in TBS and anti-mouse AlexaFluor 546
secondary antibodies (1:1000, 30 minutes).
Fluorescence signals were collected with the equipment
indicated in each Figure. Wide field epifluorescence images were
obtained in a Zeiss Axioskop 2 microscope equipped with a SPOT
1.3 camera and using the SPOT software. Confocal microscopy
was performed in a laser scanning confocal microscope (TCS-SP2;
Leica) using an oil immersion objective (HCX PL Apo, 636/
NA=1.4) or a Zeiss LSM 510 Meta device using a Plan-Neofluar
40x/1.3 Oil DIC objective. ImageJ [68] and Adobe Photoshop
were used for offline image processing. No non-linear image
modifications were performed. The JACoP plug-in [69] was used
to quantify the co-localization of KV10.1 and NPC, and the
‘‘Straighten Curved Objects’’ plugin [70] for the straightened view
shown in Figure 4C.
Nuclear isolation, surface labeling and western blot
Whole cell lysates were obtained by homogenization in
denaturing lysis buffer (50 mM NaHCO3,1 5m MN a 2CO3,2 %
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rations were obtained using the NucBuster Nuclear Protein
Extraction Kit (Novagen, Darmstadt, Germany) according to the
manufacturer’s manual except for the addition of an extraction
step of the nuclear pellet in extraction buffer +0.5% Triton X-100.
Cytochrome c assay was performed as described in [71].
For nuclear protein preparation, the nuclei were prepared by
homogenizing HEK-KV10.1 cells in hypotonic solution or minced
rat brain in nuclear isolation medium (NIM, 0.25 M sucrose,
25 mM KCl, 5 mM MgCl2, 10 mM Tris/HCl, pH 7.4). The
crude nuclear extracts were then washed twice in NIM. The nuclei
were resuspended in one volume of NIM and then mixed with two
volumes of a sucrose density barrier (SDB: 2.3 M sucrose, 25 mM
KCl, 5 mM Tris/HCl, pH 7.4). The whole mixtures were laid on
top of SDB and centrifuged at 100,000 xg for one hour. The
pellets containing nuclei were subjected to citraconic anhydride to
remove the ONM as described by [45]. Then the nuclear proteins
were prepared by the low-ionic-strength method [71].
For western blots, proteins were separated in a 3–8% gradient
polyacrylamide gel electrophoresis (Invitrogen), transferred to
nitrocellulose membranes and probed with KV10.1 antibodies
(9391). The same membranes were subsequently stripped (Restore
Western Blot Stripping Buffer, Thermo Scientific) and re-probed
with anti-LAP2 (1:2000) and anti-LUMA (1:2000).
To label surface-expressed KV10.1-AP by enzymatic biotinyla-
tion, stably transfected HEK293 cells were incubated for 20
minutes at 37uCi n1 0mM biotin and 120 nM BirA (Avidity, USA)
in PBS (containing 4 mM MgCl2 and 1 mM ATP). For 24 hours
continuous labeling, after the described incubation, culture
medium supplemented with 1 mM ATP, 10 mM biotin, 30 mM
di-sodium phosphocreatine and 30 U/mL creatine phosphokinase
was added to the reaction.
Biotin-labeled proteins were pulled-down in 2 mL NPE lysis
buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl, 5 mM
KCl, 1% NP-40, Complete Protease-inhibitors (Roche), pH 7.5)
with 30 mL Dynabeads MyOne Streptavidin T1 (Invitrogen) for
one hour at 4uC. The beads were then washed three times in NPE,
once in TBS and the proteins were recovered in NuPAGE loading
buffer.
Electrophysiological Recordings
Nuclei from HEK-KV10.1 cells were prepared essentially as
those for biochemical analysis with the addition of 10 mM EGTA
to all solutions. After sedimentation through a 2.3 M sucrose
cushion, nuclei were resuspended in NIM for ONM measure-
ments. For INM measurements, nuclei were further treated with
citraconic anhydride in modification buffer (200 mM HEPES/
NaOH pH 8.5, 1 mM MgCl2, 250 mM sucrose) and washed
twice in NIM solution. The nuclei were stored at 4uC in NIM and
measured within 36 hours of preparation.
Single channel recordings were performed using bath solution
150 mM KCl, 5 mM MgCl2,1 0mM LaCl3, 10 mM HEPES/
KOH pH 7.4. The pipette solution for symmetrical K+ recordings
was identical to the bath solution except that 200 mM CaCl2 was
added to improve seal formation. For recording in asymmetrical
K+, the pipette contained 160 mM NaCl, 2.5 mM KCl, 2 mM
CaCl2, 1 mM MgCl2,1 0 mM LaCl3, 8 mM glucose, 10 mM
HEPES/NaOH, pH 7.4. The osmolarity of all solutions was 300–
330 mmol/kg. Nuclei in suspension were allowed to attach to the
plastic bottom of the experimental chamber or to a poly-L-Lysine-
coated coverslip for 5 minutes and were then gravity perfused
extensively with bath solution to remove trace amounts of EGTA.
Ellipsoid nuclei without attached membrane debris were selected
visually for measurement. Currents were recorded using an EPC9
patch-clamp amplifier (HEKA Elektronik, Lambrecht, Germany)
in the ‘‘nucleus-attached’’ configuration. This is equivalent to the
standard cell-attached configuration for the INM, but outside-out
for the ONM. Pulse generation and data acquisition were
controlled with Pulse software (HEKA Elektronik). Data were
filtered at 1 kHz and digitized at 5 kHz. Patch pipettes were pulled
from WPI.PG10165-4 glass (World precision Instruments) or
Hilgenberg thick-wall (0.5 mm) borosilicate with a resistance of 7–
12 MV. Offline data analysis was performed using TAC (Bruxton
Corp. Seattle, US.). Astemizole (Sigma) was prepared in 10 mM
stock solution in DMSO and used at 1:5000 dilution shielded from
light. Solution exchanges were completed in 5 minutes. For
antibody blockage, the tip of pipette was loaded with normal
pipette solution and the pipette was then backfilled with 300 nM
mAb56. All electrophysiological experiments were performed at
room temperature (20–22uC).
Fluorescence recovery after photobleaching (FRAP)
CHO cells plated on 40 mm coverslips were transfected as
described above. Immediately before FRAP experiments, cells
were incubated with Hoechst 33342 (50 ng/mL, 5 minutes at
room temperature) to stain the nuclei and washed twice with TBS.
FRAP was performed using a 40x, HCX PL Fluotar, 1.25 NA oil
immersion objective on a Leica TCS SP II confocal microscope
installed in a temperature controlled chamber. Parameters were
identical in all experiments; cells were kept at 37uC in a Focht
Live-Cell Chamber System (Bioptechs Inc, Butler, US.) in
extracellular solution (160 mM NaCl, 2.5 mM KCl, 1 mM
MgCl2, 2 mM CaCl2, 8 mM Glucose, 10 mM HEPES/NaOH
pH 7.4.). At a spatial sampling frequency of 40 nm, two 2 mm
strips either on the perinuclear region or through the cytoplasm
were chosen as regions of interest (ROI). The cells were scanned at
1400 Hz with Ar 514 laser at transmission of 7% every 0.47
seconds for 5 times before bleaching as the reference images, in
12-bit, 5126512 pixels format and then ROI were bleached 20
times at 100% transmission. The first 10, 15 and the last 15 post-
bleached images were taken every 0.47, 5 and 20 seconds
correspondingly. The emission light was collected in the range of
527 nm to 608 nm.
All the images were background-subtracted and then all the
post-bleach images were corrected for photobleaching on the
principle that the fluorescence intensity of whole post-bleached
images should stay the same as the intensity outside the ROI in the
reference images. Then the time-lapse images were corrected for
lateral drift using StackReg [72].
The fluorescence intensities of the ROIs were normalized to a
function of time [73].
Ft ðÞ
0~
Ft ðÞ {F0
Fpre{F0
ð1Þ
F (t) is the fluorescence intensity of the ROI at time t. F0 is the ROI
intensity of the first post-bleach image and Fpre is the average ROI
intensity of the first 5 reference images. F (t) ’ is the ROI fractional
fluorescence intensity at time t. The diffusion coefficient D was
calculated by fitting the data with [42]:
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where D is the one-dimensional diffusion constant; v is the width
of the strip or the square, (2 mm in our case). t0 was taken as the
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approaches infinity. All the data fitting was processed by Igor Pro
6.0.2 (WaveMetrics, Inc. Lake Oswego, OR).
Based on the fitting curves, the mobile fractions (Mf) were
calculated as:
Mf~100|
F?{F0
Fpre{F0
ð3Þ
where F0 is the fractional intensity at t0.
Freeze-substitution and postembedding immunogold
labeling
MCF7 cells (DSMZ, see above) and hippocampal and cerebellar
slices from 3 Sprague-Dawley rats (Harlan Research Laboratories)
were used for freeze substitution. Cell cultures were immersion
fixed with 4% paraformaldehyde and 0.5% glutaraldehyde in 0.1
M phosphate buffer, pH 7.15, for 1.5 hours. Rats for the
hippocampal and cerebellar analysis were transcardially perfused
and post-fixed with the same fixative. After fixation, a freeze
substitution protocol similar to that described previously was used
[74,75]. Hippocampal and cerebellar regions were carefully
dissected and processed for freeze-substitution and low-tempera-
ture embedding. For post-embedding immunocytochemistry,
ultrathin sections (80 nm in thickness) on nickel grids were
incubated in sodium borohydride and glycine in Tris-buffered
saline solution with Triton X-100. After being pre-blocked with
serum, the sections were incubated with affinity-purified primary
antibody mAb62 (1 mg/mL; 1:200 dilution). Primary antibody was
detected with secondary antibodies conjugated to 5 nm gold
particles (1:20; Amersham, Arlington Heights, USA). In some
ultrathin sections from cerebellum, the gold conjugated secondary
antibody was silver intensified using the Aurion silver enhance-
ment kit (Aurion, Wageningen, The Netherlands).The specificity
of the antibody has been established previously [1]. Controls
included omitting mAb62 and pre-absorption of mAb62 with the
corresponding blocking protein (10 mg/mL final concentration).
Ultrathin sections were counterstained with uranyl acetate and
lead citrate and studied with a transmission electron microscope.
Electron micrographs were taken at 30,000x magnification and
scanned at a resolution of 3600 dpi using a Linotype-Hell scanner
(Heidelberg, Germany). Image processing was performed with
Adobe Photoshop using only the brightness and contrast
commands to enhance gold particles.
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